Targeting the CNOT2/VEGF pathway by Cornin attenuates angiogenesis and invasion in cervical cancer cells

Ah Reum Cho1, Su-Yeon Park1, Deok Yong Sim1

  • 1Department of Korean Medicine, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.

Scientific Reports
|April 27, 2026
PubMed

Insights

Cornin, a natural compound, inhibits cervical cancer growth by targeting the CNOT2-VEGF pathway, reducing tumor blood vessel formation and spread. This suggests Cornin as a potential anti-cancer agent.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cornin, from Cornus officinalis, has known cardioprotective effects.
  • Its antitumor mechanisms in cervical cancer are not well understood.
  • Focus on the CNOT2-VEGF signaling axis for anti-cancer effects.

Purpose of the Study:

  • Investigate Cornin's antiangiogenic and anti-invasive effects in cervical cancer.
  • Elucidate the role of the CNOT2-VEGF signaling axis in Cornin's action.
  • Evaluate Cornin as a potential therapeutic agent for cervical cancer.

Main Methods:

  • Cell culture (SiHa, HeLa, CaSki) and functional assays (migration, invasion, wound healing).
  • Gene expression analysis (CNOT2, N-cadherin, VEGF, Snail) and protein stability assays (cycloheximide chase).
  • In vitro angiogenesis (HUVEC tube formation) and in vivo models (chick CAM assay), TCGA data analysis, immunoprecipitation.

Main Results:

  • Cornin downregulated CNOT2, N-cadherin, VEGF, and Snail in HeLa and SiHa cells.
  • Cornin inhibited cell migration, invasion, VEGF secretion, and angiogenesis.
  • CNOT2 expression correlated with VEGF in cervical cancer tissues and physically interacted with VEGF.

Conclusions:

  • Cornin exhibits antiangiogenic and anti-invasive properties in cervical cancer via the CNOT2-VEGF axis.
  • Cornin reduces tumor angiogenesis and invasion by modulating CNOT2 and VEGF.
  • Cornin shows potential as a natural inhibitor for cervical cancer therapy.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K